Loading...

Dominant-Negative Mechanism of Leukemogenic PAX5 Fusions

PAX5 encodes a master regulator of B-cell development. It fuses to other genes associated with acute lymphoblastoid leukemia (ALL). These fusion products are potent dominant-negative (DN) inhibitors of wild-type PAX5 resulting in a blockade of B-cell differentiation. Here, we show that multimerizati...

Full description

Saved in:
Bibliographic Details
Main Authors: Kawamata, Norihiko, Pennella, Mario A., Woo, Jennifer L., Berk, Arnold J., Koeffler, H. Phillip
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3197879/
https://ncbi.nlm.nih.gov/pubmed/21765475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.291
Tags: Add Tag
No Tags, Be the first to tag this record!